Madison, WI, January 9, 2024 – Cellular Logistics Inc. (CL) in Madison, Wisconsin, and Allele Biotechnology Inc. (ALLELE) in San Diego, California, have entered a collaboration to develop regenerative medicine products to treat ischemic heart disease. The relationship has been recently bolstered by the Catalyze award that...
Cellular Logistics Receives Second SBIR Advance Award...
MADISON, Wis., October 24, 2022 – Cellular Logistics has been awarded a $337,000 SBIR grant from the National Institutes of Health to further evaluate the functional immune and angiogenic (blood vessel growth) responses of the company's Cardiac Fibroblast Matrix product, CFX™ Solus, for the treatment...
New study identifies protein essential to form stem cell-derived human heart cells...
MADISON, WI, May 16, 2022 – Cellular Logistics, a Madison, Wisconsin company that is creating a new way to restore heart function and help patients with heart damage is launching a new financing round to advance its product, Tandem™, to the next stage of product development, and moving...
MADISON, WI, May 10, 2022 – Cellular Logistics, a Madison-area company that is creating a new way to restore heart function and help patients with heart damage has been chosen to present at the Midwest Growth Capital Symposium (MGCS) being held on May 17-18, 2022. 2022...
Cellular Logistics Receives Commercialization Funding...
MADISON, WI, November 23, 2021 – Cellular Logistics, a Madison-area company that is creating a new way to restore heart function and help patients with heart damage announces promising early data using its Tandem™ biomatrix technology. Investigators at the University of Wisconsin-Madison, led by Drs....
Cellular Logistics Selected to Pitch at the Wisconsin Early Stage Symposium...
Early-stage biotech startups find common ground at Forward BIOLABS...